| abstract |
Disclosed is a 1-phenyl 1-thio-D-glucitol compound having the formula (I) or the like, a pharmaceutically acceptable salt thereof, a hydrate of the compound or the pharmaceutically acceptable salt, or a pharmaceutical agent comprising the compound, the pharmaceutically acceptable salt or the hydrate as an active ingredient, which can inhibit both the activities of SGLT1 and SGLT2 and has both of an effect of inhibiting the absorption of glucose through a digestive tract and an urinary glucose excretion effect, and therefore is useful as a new type of prophylactic or therapeutic agent for diabetes, a diabetes-related disease or a diabetic complication. |